Black Rock Inc. Virios Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 755 shares of VIRI stock, worth $166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
755
Previous 755
-0.0%
Holding current value
$166
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VIRI
# of Institutions
22Shares Held
681KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA209KShares$45,9540.0% of portfolio
-
Geode Capital Management, LLC Boston, MA174KShares$38,3830.0% of portfolio
-
State Street Corp Boston, MA52.8KShares$11,6220.0% of portfolio
-
Mc Collum Christoferson Group LLC Amherst, NY42KShares$9,2400.01% of portfolio
-
Raymond James & Associates St Petersburg, FL30KShares$6,6000.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $4.03M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...